What Diseases Does Folding@home Research?

Folding@home directs its distributed computing power at a specific set of diseases, and the project's own site names four with concrete results: cancer, COVID-19, Alzheimer's, and Ebola. Each has a distinct research finding attached, not just a general claim of "disease research." If you want to know whether your donated compute time goes toward something with published outcomes, these four are the documented examples.

Cancer: BRCA1 and breast cancer

Folding@home's work on BRCA1 revealed new therapeutic strategies to combat breast cancer. BRCA1 is a protein whose malfunction is linked to hereditary breast and ovarian cancer, and understanding how it folds and interacts with other molecules is the kind of problem that benefits from massive parallel simulation.

COVID-19: exascale computing and an antiviral lead

During the COVID-19 pandemic, Folding@home reached 2.43 exaflops — the first computing system in history to cross the exaflop threshold, according to the project. That capacity helped identify a potential new antiviral that advanced to animal testing. This is the clearest example of the project's scale translating into a specific drug candidate.

Alzheimer's: the ApoE mechanism

The project's ApoE research is uncovering the mechanism behind the most common cause of dementia. ApoE (apolipoprotein E) is the strongest genetic risk factor for late-onset Alzheimer's, and figuring out how its variants behave at the molecular level is a prerequisite for designing interventions.

Ebola: finding hidden pockets

Folding@home found new ways to thwart Ebola by identifying transient "cryptic-pockets" in the virus protein — binding sites that other methods had missed. Cryptic pockets are short-lived openings in a protein's surface that can be targeted by drugs but are invisible to static structural analysis. This is a case where simulation's ability to capture motion, not just shape, produced the insight.

How these results fit the bigger picture

The project reports 500+ peer-reviewed papers since its launch in October 2000 and 25+ years of continuous operation, led by Dr. Greg Bowman and the Folding@home Consortium — a network of academic labs worldwide. Those numbers matter because they indicate the disease-specific findings above are part of a sustained, published body of work rather than isolated announcements.

What this means if you're deciding whether to contribute

The diseases listed are the ones the project itself highlights with results, so they're a reasonable proxy for where your compute time is most likely to go. Contributing requires downloading a client for Windows, macOS, or Linux, running the installer, and letting it work in the background — no account is required to start, and the client is open source. If you want to check current research priorities or read the underlying papers before committing, the project's live stats, forum, Discord, GitHub, and research update channels are the places to look.